Medical Xpress·3 min read·hard
Inhibiting protein to treat myeloproliferative neoplasms shows preclinical promise
S
St. Jude Children's Research Hospital
✦AI Summary
Researchers at St. Jude Children's Research Hospital have discovered that inhibiting the menin protein shows promise in treating myeloproliferative neoplasms. Preclinical studies in mice demonstrated improved survival rates and normalized blood cell counts.
Why it matters
This discovery offers a potential new therapeutic pathway for rare blood cancers, building on existing FDA-approved treatments for leukemia.
edited by Gaby Clark , reviewed by Andrew Zinin
healthscience
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 95%
The article summarizes scientific research findings based on a peer-reviewed study.
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in